Inventor · disambiguated record
Paul Fredrick Widboom
Also filed as: WIDBOOM PAUL · WIDBOOM PAUL FREDRICK
13 granted patents·10 pending applications·58 citations·filing 2013–2025
90Inventor score
Files withCOMPASS THERAPEUTICS LLC10TRISHULA THERAPEUTICS INC5TIZONA THERAPEUTICS3ADIMAB LLC2THERINI BIO INC2
Top patents by PatentIndex Score
23 records- 0196US10716851B2Agonist antibodies that bind human CD137 and uses thereofCOMPASS THERAPEUTICS LLC·Filed 2018·Granted Jul 21, 2020·10 cites·5 claims
- 0296US10350292B1Agonist antibodies that bind human CD137 and uses thereofCOMPASS THERAPEUTICS LLC·Filed 2019·Granted Jul 16, 2019·12 cites·28 claims
- 0396US10279039B2Agonist antibodies that bind human CD137 and uses thereofCOMPASS THERAPEUTICS LLC·Filed 2018·Granted May 7, 2019·10 cites·20 claims
- 0496US10279038B2Agonist antibodies that bind human CD137 and uses thereofCOMPASS THERAPEUTICS LLC·Filed 2018·Granted May 7, 2019·11 cites·16 claims
- 0596US10279040B1Agonist antibodies that bind human CD137 and uses thereofCOMPASS THERAPEUTICS LLC·Filed 2018·Granted May 7, 2019·10 cites·20 claims
- 0695US10434175B2Agonist antibodies that bind human CD137 and uses thereofCOMPASS THERAPEUTICS LLC·Filed 2019·Granted Oct 8, 2019·5 cites·20 claims
- 0787US2024181050A1Agonist antibodies that bind human cd137 and uses thereofCOMPASS THERAPEUTICS LLC·Filed 2023·Application pending·0 cites
- 0878US2020046833A1Agonist antibodies that bind human cd137 and uses thereofCOMPASS THERAPEUTICS LLC·Filed 2019·Application pending·0 cites
- 0977US2025026850A1Anti-cd39 antibodies, compositions comprising anti-cd39 antibodies and methods of using anti-cd39 antibodiesTRISHULA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1076US12209135B2Anti-CD45 antibodies and conjugates thereofVOR BIOPHARMA INC·Filed 2024·Granted Jan 28, 2025·0 cites·22 claims
- 1175US11752207B2Agonist antibodies that bind human CD137 and uses thereofCOMPASS THERAPEUTICS LLC·Filed 2020·Granted Sep 12, 2023·0 cites·13 claims
- 1266US12269894B2Antibodies which bind human fibrin or fibrinogen γC domain and methods of useTHERINI BIO INC·Filed 2024·Granted Apr 8, 2025·0 cites·21 claims
- 1366US2022372163A1Anti-cd39 antibodies, compositions comprising anti-cd39 antibodies and methods of using anti-cd39 antibodiesTRISHULA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1466US2022340680A1Anti-cd39 antibodies, compositions comprising anti-cd39 antibodies and methods of using anti-cd39 antibodiesTRISHULA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1565US2021403593A1Anti-cd39 antibodies, compositions comprising anti-cd39 antibodies and methods of using anti-cd39 antibodiesTRISHULA THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1662US12264199B2Anti-HLA-G antibodies, compositions comprising anti-HLA-G antibodies and methods of using anti-HLA-G antibodiesTIZONA THERAPEUTICS·Filed 2021·Granted Apr 1, 2025·0 cites·7 claims
- 1759US2025353913A1Anti-hla-g antibodies, compositions comprising anti-hla-g antibodies and methods of using anti-hla-g antibodiesTIZONA THERAPEUTICS·Filed 2025·Application pending·0 cites
- 1858US11345757B2Anti-CD39 antibodiesTRISHULA THERAPEUTICS INC·Filed 2018·Granted May 31, 2022·0 cites·7 claims
- 1958US11208487B2Anti-HLA-G antibodies, compositions comprising anti-HLA-G antibodies and methods of using anti-HLA-G antibodiesTIZONA THERAPEUTICS·Filed 2019·Granted Dec 28, 2021·0 cites·10 claims
- 2054US12460004B2Antibodies that bind CD277 and uses thereofCOMPASS THERAPEUTICS LLC·Filed 2019·Granted Nov 4, 2025·0 cites·12 claims
- 2153US2024279321A1ANTIBODIES WHICH BIND HUMAN FIBRIN OR FIBRINOGEN yC DOMAIN AND METHODS OF USETHERINI BIO INC·Filed 2022·Application pending·0 cites
- 2251US2023265134A1Ch1 domain variants engineered for preferential light chain pairing and multispecific antibodies comprising the sameADIMAB LLC·Filed 2020·Application pending·0 cites
- 2346US2014377269A1Multivalent antibody analogs, and methods of their preparation and useADIMAB LLC·Filed 2013·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Paul Fredrick Widboom files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →